サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：集団検診の市場シェア、規模、動向、産業分析レポート：地理別、製品別、用途別、地域別、セグメント予測、2023年～2032年
市場調査レポート
商品コード
1287714

集団検診の市場シェア、規模、動向、産業分析レポート：地理別、製品別、用途別、地域別、セグメント予測、2023年～2032年

Population Screening Market Share, Size, Trends, Industry Analysis Report, By geography (Nation, State); By Product; By Application; By Region; Segment Forecast, 2023 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 117 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.91円
集団検診の市場シェア、規模、動向、産業分析レポート：地理別、製品別、用途別、地域別、セグメント予測、2023年～2032年
出版日: 2023年04月01日
発行: Polaris Market Research
ページ情報: 英文 117 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Researchの新しい調査によると、世界の集団検診市場規模は2032年までに439億1,000万米ドルに達すると予想されています。本レポートでは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

病気の発見と治療に関する意識の高まりは、集団検診市場の成長に影響を与える重要な要因になるでしょう。また、都市化の進展と可処分所得の増加が、健康検診市場の発展を加速させる要因となっています。さらに、ヘルスケアインフラへの支出の増加や人々のライフスタイルの変化は、健康検診市場を前進させる主要な市場促進要因となっています。

予防医療への重点化、技術的に高度な製品の発売、研究開発活動の活発化、生活水準の向上につながる一人当たり所得の増加、健康的なライフスタイルの利点に関する意識の高まりは、予測期間中の市場成長を促進すると期待されています。このように、政府がイニシアチブをとることが、市場を牽引しています。例えば、マハラシュトラ州政府は2022年10月、同州の女性の安全を守るための予防措置として、集団検診キャンペーンを発表しました。このキャンペーンの一環として様々な健康関連検査が実施され、3,000万人の女性の集団検診が完了する予定です。

ヘルスケアデータの量と入手可能性の増大、そして患者に質の高いケアを提供する必要性の高まりにより、医療機関はこれらの新しい方法論に頼らざるを得なくなります。これは、競合他社との差別化を図り、成長機会を生かすための戦略的コンピテンシーとして活用されるでしょう。

国内の集団検診市場は、COVID-19のパンデミックから恩恵を受けると予想されています。例えば、Hayatt Med-Techスタートアップは、2021年6月にCOVID-19検査を迅速に行うための全自動Hayatt Thermox-Dを作成しました。各セッション後の自己消毒により、このデバイスは12秒で複数のパラメーターを検診し、急性症状を検出することができます。このように、新しい分析技術の導入は、市場の拡大を後押しすると期待されています。

集団検診市場レポートハイライト

  • CTCが提供するがん検出の有効性と精度の高さから、国分野は予測期間中に成長すると予測される
  • ハードウェア機器セグメントが2022年に市場で圧倒的なシェアを占めるより多くの疾患の集団検診を拡大するために、新しいテストキットやツールが受け入れられているため
  • 慢性疾患の有病率の上昇、複数の検査オプションの利用可能性、より良い、より効果的な患者スクリーニングのための新しい検査の導入により、2022年に最も収益を上げるのは病院セグメントであろう。
  • 北米は、疾病の進行を食い止めるために政府が実施する予防措置により、2022年に集団検診市場を独占すると思われます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の集団検診市場に関する洞察

  • 集団検診市場- 用途のスナップショット
  • 集団検診市場力学
    • 促進要因と機会
      • 病気の蔓延の増加
      • 集団検診への投資の拡大
    • 抑制要因と課題
      • スクリーニングに伴う高額な費用
  • PESTEL分析
  • 集団検診市場の用途動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界の集団検診市場、地理別

  • 主な調査結果
  • イントロダクション
  • 国
  • 州

第6章 世界の集団検診市場、製品別

  • 主な調査結果
  • イントロダクション
  • ハードウェア設備
  • テスト/ラボ
  • 分析/解釈

第7章 世界の集団検診市場、用途別

  • 主な調査結果
  • イントロダクション
  • 病院
  • 研究機関
  • 診断ラボ

第8章 世界の集団検診市場、地域別

  • 主な調査結果
  • イントロダクション
    • 集団検診市場評価、地域別、2019-2032年
  • 集団検診市場-北米
    • 北米：集団検診市場、地域別、2019-2032年
    • 北米：集団検診市場、用途別、2019～2032年
    • 北米：集団検診市場、製品別、2019～2032年
    • 集団検診市場-米国
    • 集団検診市場- カナダ
  • 集団検診市場- 欧州
    • 欧州：集団検診市場、地域別、2019-2032
    • 欧州：集団検診市場、用途別、2019～2032年
    • 欧州：集団検診市場、製品別、2019～2032年
    • 集団検診市場- 英国
    • 集団検診市場- フランス
    • 集団検診市場- ドイツ
    • 集団検診市場- イタリア
    • 集団検診市場- スペイン
    • 集団検診市場- オランダ
    • 集団検診市場- ロシア
  • 集団検診市場- アジア太平洋
    • アジア太平洋地域：集団検診市場、地域別、2019～2032年
    • アジア太平洋：集団検診市場、用途別、2019～2032年
    • アジア太平洋地域：集団検診市場、製品別、2019～2032年
    • 集団検診市場- 中国
    • 集団検診市場- インド
    • 集団検診市場- マレーシア
    • 集団検診市場- 日本
    • 集団検診市場- インドネシア
    • 集団検診市場- 韓国
  • 集団検診市場-中東およびアフリカ
    • 中東およびアフリカ：集団検診市場、地域別、2019-2032
    • 中東およびアフリカ：集団検診市場、用途別、2019～2032年
    • 中東およびアフリカ：集団検診市場、製品別、2019～2032年
    • 集団検診市場- サウジアラビア
    • 集団検診市場- アラブ首長国連邦
    • 集団検診市場- イスラエル
    • 集団検診市場- 南アフリカ
  • 集団検診市場-ラテンアメリカ
    • ラテンアメリカ：集団検診市場、地域、2019-2032年
    • ラテンアメリカ：集団検診市場、用途別、2019～2032年
    • ラテンアメリカ：集団検診市場、製品別、2019～2032年
    • 集団検診市場- メキシコ
    • 集団検診市場- ブラジル
    • 集団検診市場- アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡張
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Agilent Technologies
  • QIAGEN
  • Roche Ltd
  • Quest Diagnostics
  • Illumina
  • ARUP Laboratories
  • Thermo Fisher Scientific
  • Novogene
  • LGC Limited
  • Gene by Gene Ltd
  • Evoq Technologies
  • Eurofins
図表

List of Tables

  • Table 1 Global Population Screening Market, by Geography, 2019-2032 (USD Billion)
  • Table 2 Global Population Screening Market, by Product, 2019-2032 (USD Billion)
  • Table 3 Global Population Screening Market, by Application, 2019-2032 (USD Billion)
  • Table 4 Population Screening Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Population Screening Market, by Geography, 2019-2032 (USD Billion)
  • Table 6 North America: Population Screening Market, by Product, 2019-2032 (USD Billion)
  • Table 7 North America: Population Screening Market, by Application, 2019-2032 (USD Billion)
  • Table 8 U.S.: Population Screening Market, by Geography, 2019-2032 (USD Billion)
  • Table 9 U.S.: Population Screening Market, by Product, 2019-2032 (USD Billion)
  • Table 10 U.S.: Population Screening Market, by Application, 2019-2032 (USD Billion)
  • Table 11 Canada: Population Screening Market, by Geography, 2019-2032 (USD Billion)
  • Table 12 Canada: Population Screening Market, by Product, 2019-2032 (USD Billion)
  • Table 13 Canada: Population Screening Market, by Application, 2019-2032 (USD Billion)
  • Table 14 Europe: Population Screening Market, by Geography, 2019-2032 (USD Billion)
  • Table 15 Europe: Population Screening Market, by Product, 2019-2032 (USD Billion)
  • Table 16 Europe: Population Screening Market, by Application, 2019-2032 (USD Billion)
  • Table 17 UK: Population Screening Market, by Geography, 2019-2032 (USD Billion)
  • Table 18 UK: Population Screening Market, by Product, 2019-2032 (USD Billion)
  • Table 19 UK: Population Screening Market, by Application, 2019-2032 (USD Billion)
  • Table 20 France: Population Screening Market, by Geography, 2019-2032 (USD Billion)
  • Table 21 France: Population Screening Market, by Product, 2019-2032 (USD Billion)
  • Table 22 France: Population Screening Market, by Application, 2019-2032 (USD Billion)
  • Table 23 Germany: Population Screening Market, by Geography, 2019-2032 (USD Billion)
  • Table 24 Germany: Population Screening Market, by Product, 2019-2032 (USD Billion)
  • Table 25 Germany: Population Screening Market, by Application, 2019-2032 (USD Billion)
  • Table 26 Italy: Population Screening Market, by Geography, 2019-2032 (USD Billion)
  • Table 27 Italy: Population Screening Market, by Product, 2019-2032 (USD Billion)
  • Table 28 Italy: Population Screening Market, by Application, 2019-2032 (USD Billion)
  • Table 29 Spain: Population Screening Market, by Geography, 2019-2032 (USD Billion)
  • Table 30 Spain: Population Screening Market, by Product, 2019-2032 (USD Billion)
  • Table 31 Spain: Population Screening Market, by Application, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Population Screening Market, by Geography, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Population Screening Market, by Product, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Population Screening Market, by Application, 2019-2032 (USD Billion)
  • Table 35 Russia: Population Screening Market, by Geography, 2019-2032 (USD Billion)
  • Table 36 Russia: Population Screening Market, by Product, 2019-2032 (USD Billion)
  • Table 37 Russia: Population Screening Market, by Application, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Population Screening Market, by Geography, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Population Screening Market, by Product, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Population Screening Market, by Application, 2019-2032 (USD Billion)
  • Table 41 China: Population Screening Market, by Geography, 2019-2032 (USD Billion)
  • Table 42 China: Population Screening Market, by Product, 2019-2032 (USD Billion)
  • Table 43 China: Population Screening Market, by Application, 2019-2032 (USD Billion)
  • Table 44 India: Population Screening Market, by Geography, 2019-2032 (USD Billion)
  • Table 45 India: Population Screening Market, by Product, 2019-2032 (USD Billion)
  • Table 46 India: Population Screening Market, by Application, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Population Screening Market, by Geography, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Population Screening Market, by Product, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Population Screening Market, by Application, 2019-2032 (USD Billion)
  • Table 50 Japan: Population Screening Market, by Geography, 2019-2032 (USD Billion)
  • Table 51 Japan: Population Screening Market, by Product, 2019-2032 (USD Billion)
  • Table 52 Japan: Population Screening Market, by Application, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Population Screening Market, by Geography, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Population Screening Market, by Product, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Population Screening Market, by Application, 2019-2032 (USD Billion)
  • Table 56 South Korea: Population Screening Market, by Geography, 2019-2032 (USD Billion)
  • Table 57 South Korea: Population Screening Market, by Product, 2019-2032 (USD Billion)
  • Table 58 South Korea: Population Screening Market, by Application, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Population Screening Market, by Geography, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Population Screening Market, by Product, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Population Screening Market, by Application, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Population Screening Market, by Geography, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Population Screening Market, by Product, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Population Screening Market, by Application, 2019-2032 (USD Billion)
  • Table 65 UAE: Population Screening Market, by Geography, 2019-2032 (USD Billion)
  • Table 66 UAE: Population Screening Market, by Product, 2019-2032 (USD Billion)
  • Table 67 UAE: Population Screening Market, by Application, 2019-2032 (USD Billion)
  • Table 68 Israel: Population Screening Market, by Geography, 2019-2032 (USD Billion)
  • Table 69 Israel: Population Screening Market, by Product, 2019-2032 (USD Billion)
  • Table 70 Israel: Population Screening Market, by Application, 2019-2032 (USD Billion)
  • Table 71 South Africa: Population Screening Market, by Geography, 2019-2032 (USD Billion)
  • Table 72 South Africa: Population Screening Market, by Product, 2019-2032 (USD Billion)
  • Table 73 South Africa: Population Screening Market, by Application, 2019-2032 (USD Billion)
  • Table 74 Latin America: Population Screening Market, by Geography, 2019-2032 (USD Billion)
  • Table 75 Latin America: Population Screening Market, by Product, 2019-2032 (USD Billion)
  • Table 76 Latin America: Population Screening Market, by Application, 2019-2032 (USD Billion)
  • Table 77 Mexico: Population Screening Market, by Geography, 2019-2032 (USD Billion)
  • Table 78 Mexico: Population Screening Market, by Product, 2019-2032 (USD Billion)
  • Table 79 Mexico: Population Screening Market, by Application, 2019-2032 (USD Billion)
  • Table 80 Brazil: Population Screening Market, by Geography, 2019-2032 (USD Billion)
  • Table 81 Brazil: Population Screening Market, by Product, 2019-2032 (USD Billion)
  • Table 82 Brazil: Population Screening Market, by Application, 2019-2032 (USD Billion)
  • Table 83 Argentina: Population Screening Market, by Geography, 2019-2032 (USD Billion)
  • Table 84 Argentina: Population Screening Market, by Product, 2019-2032 (USD Billion)
  • Table 85 Argentina: Population Screening Market, by Application, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Population Screening Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Population Screening Market, by Product, 2021 & 2030 (USD Billion)
  • Figure 8. Market by Geography
  • Figure 9. Global Population Screening Market, by Geography, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Application
  • Figure 11. Global Population Screening Market, by Application, 2021 & 2030 (USD Billion)
  • Figure 12. Population Screening Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Population Screening Market
目次
Product Code: PM3184

The global population screening market size is expected to reach USD 43.91 billion by 2032, according to a new study by Polaris Market Research. The report "Population Screening Market Share, Size, Trends, Industry Analysis Report, By Geography (Nation, State); By Product; By Application; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Rising awareness about disease detection and treatment will be a significant factor influencing the growth of the health screening market. In addition, increasing urbanization and disposable income are driving factors accelerating the development of the health screening market. Furthermore, rising healthcare infrastructure spending and people's ever-changing lifestyles are major market drivers that will propel the health screening market forward.

Increasing emphasis on preventive healthcare, the launch of technologically advanced products, growing research and development activities, rising per capita income leading to improving the standard of living, and increasing awareness about the advantages of a healthy lifestyle are expected to propel the market growth during the forecast period. Thus, the government takes the initiative, which drives the market. For instance, The Maharashtra state government announced a health check-up campaign in October 2022 as a preventive measure for women's safety in the state. Various health-related tests will be performed as part of this campaign to complete 30 million women's health tests.

The growing volume and availability of healthcare data and the increasing need to provide quality care to patients will force healthcare organizations to rely on these new methodologies. This will be used as a strategic competency to distinguish themselves from competitors and capitalize on growth opportunities.

The nation's population screening market is anticipated to benefit from the COVID-19 pandemic. For instance, Hayatt Med-Tech startup created the fully automated Hayatt Thermox-D in June 2021 to perform quick COVID-19 testing. With self-disinfection after each session, this device can screen multiple parameters and detect acute symptoms in 12 seconds. Thus, introducing new analytical technologies is expected to boost market expansion.

Population Screening Market Report Highlights

  • Nation segment is anticipated to grow over the forecast period because of the effectiveness and precision offered by CTCs in cancer detection
  • The hardware equipment segment held a dominant share of the market in 2022 Because of the acceptance of new test kits and tools for expanding population screening of more diseases
  • The hospital segment will generate the most revenue in 2022 owing to the rising prevalence of chronic diseases, the availability of multiple testing options, and the introduction of new tests for better and more effective patient screening.
  • North America will dominate the population screening market in 2022, owing to preventive measures implemented by governments to halt disease progression.
  • The global players include: Agilent Technologies, Thermo Fisher Scientific, QIAGEN, Roche Ltd., Quest Diagnostics, and Illumina

Polaris Market Research has segmented the population screening market report based on geography, product, application, and region:

Population screening, Geography Outlook (Revenue - USD Billion, 2019 - 2032)

  • Nation
  • State

Population screening, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hardware Equipment
  • Testing / Lab
  • Analytics / Interpretation

Population screening, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospitals
  • Research Institutes
  • Diagnostic Labs

Population screening, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Geographys
    • 3.2.1. Primary Geographys
    • 3.2.2. Secondary Geographys

4. Global Population Screening Market Insights

  • 4.1. Population Screening Market - Application Snapshot
  • 4.2. Population Screening Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Prevalence Of Diseases
      • 4.2.1.2. Growing Investments In Population Screening
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost Associated With Screening
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Population Screening Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Population Screening Market, by Geography

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Population Screening Market, by Geography, 2019-2032 (USD Billion)
  • 5.3. Nation
    • 5.3.1. Global Population Screening Market, by Nation, by Region, 2019-2032 (USD Billion)
  • 5.4. State
    • 5.4.1. Global Population Screening Market, by State, by Region, 2019-2032 (USD Billion)

6. Global Population Screening Market, by Product

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Population Screening Market, by Product, 2019-2032 (USD Billion)
  • 6.3. Hardware Equipment
    • 6.3.1. Global Population Screening Market, by Hardware Equipment, by Region, 2019-2032 (USD Billion)
  • 6.4. Testing / Lab
    • 6.4.1. Global Population Screening Market, by Testing / Lab, by Region, 2019-2032 (USD Billion)
  • 6.5. Analytics / Interpretation
    • 6.5.1. Global Population Screening Market, by Analytics / Interpretation, by Region, 2019-2032 (USD Billion)

7. Global Population Screening Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Population Screening Market, by Application, 2019-2032 (USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Global Population Screening Market, by Hospitals, By Region, 2019-2032 (USD Billion)
  • 7.4. Research Institutes
    • 7.4.1. Global Population Screening Market, by Research Institutes, By Region, 2019-2032 (USD Billion)
  • 7.5. Diagnostic Labs
    • 7.5.1. Global Population Screening Market, by Diagnostic Labs, By Region, 2019-2032 (USD Billion)

8. Global Population Screening Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Population Screening Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Population Screening Market - North America
    • 8.3.1. North America: Population Screening Market, by Geography, 2019-2032 (USD Billion)
    • 8.3.2. North America: Population Screening Market, by Application, 2019-2032 (USD Billion)
    • 8.3.3. North America: Population Screening Market, by Product, 2019-2032 (USD Billion)
    • 8.3.4. Population Screening Market - U.S.
      • 8.3.4.1. U.S.: Population Screening Market, by Geography, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Population Screening Market, by Application, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Population Screening Market, by Product, 2019-2032 (USD Billion)
    • 8.3.5. Population Screening Market - Canada
      • 8.3.5.1. Canada: Population Screening Market, by Geography, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Population Screening Market, by Application, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Population Screening Market, by Product, 2019-2032 (USD Billion)
  • 8.4. Population Screening Market - Europe
    • 8.4.1. Europe: Population Screening Market, by Geography, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Population Screening Market, by Application, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Population Screening Market, by Product, 2019-2032 (USD Billion)
    • 8.4.4. Population Screening Market - UK
      • 8.4.4.1. UK: Population Screening Market, by Geography, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Population Screening Market, by Application, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Population Screening Market, by Product, 2019-2032 (USD Billion)
    • 8.4.5. Population Screening Market - France
      • 8.4.5.1. France: Population Screening Market, by Geography, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Population Screening Market, by Application, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Population Screening Market, by Product, 2019-2032 (USD Billion)
    • 8.4.6. Population Screening Market - Germany
      • 8.4.6.1. Germany: Population Screening Market, by Geography, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Population Screening Market, by Application, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Population Screening Market, by Product, 2019-2032 (USD Billion)
    • 8.4.7. Population Screening Market - Italy
      • 8.4.7.1. Italy: Population Screening Market, by Geography, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Population Screening Market, by Application, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Population Screening Market, by Product, 2019-2032 (USD Billion)
    • 8.4.8. Population Screening Market - Spain
      • 8.4.8.1. Spain: Population Screening Market, by Geography, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Population Screening Market, by Application, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Population Screening Market, by Product, 2019-2032 (USD Billion)
    • 8.4.9. Population Screening Market - Netherlands
      • 8.4.9.1. Netherlands: Population Screening Market, by Geography, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Population Screening Market, by Application, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Population Screening Market, by Product, 2019-2032 (USD Billion)
    • 8.4.10. Population Screening Market - Russia
      • 8.4.10.1. Russia: Population Screening Market, by Geography, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Population Screening Market, by Application, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Population Screening Market, by Product, 2019-2032 (USD Billion)
  • 8.5. Population Screening Market - Asia Pacific
    • 8.5.1. Asia Pacific: Population Screening Market, by Geography, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Population Screening Market, by Application, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Population Screening Market, by Product, 2019-2032 (USD Billion)
    • 8.5.4. Population Screening Market - China
      • 8.5.4.1. China: Population Screening Market, by Geography, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Population Screening Market, by Application, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Population Screening Market, by Product, 2019-2032 (USD Billion)
    • 8.5.5. Population Screening Market - India
      • 8.5.5.1. India: Population Screening Market, by Geography, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Population Screening Market, by Application, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Population Screening Market, by Product, 2019-2032 (USD Billion)
    • 8.5.6. Population Screening Market - Malaysia
      • 8.5.6.1. Malaysia: Population Screening Market, by Geography, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Population Screening Market, by Application, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Population Screening Market, by Product, 2019-2032 (USD Billion)
    • 8.5.7. Population Screening Market - Japan
      • 8.5.7.1. Japan: Population Screening Market, by Geography, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Population Screening Market, by Application, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Population Screening Market, by Product, 2019-2032 (USD Billion)
    • 8.5.8. Population Screening Market - Indonesia
      • 8.5.8.1. Indonesia: Population Screening Market, by Geography, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Population Screening Market, by Application, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Population Screening Market, by Product, 2019-2032 (USD Billion)
    • 8.5.9. Population Screening Market - South Korea
      • 8.5.9.1. South Korea: Population Screening Market, by Geography, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Population Screening Market, by Application, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Population Screening Market, by Product, 2019-2032 (USD Billion)
  • 8.6. Population Screening Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Population Screening Market, by Geography, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Population Screening Market, by Application, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Population Screening Market, by Product, 2019-2032 (USD Billion)
    • 8.6.4. Population Screening Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Population Screening Market, by Geography, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Population Screening Market, by Application, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Population Screening Market, by Product, 2019-2032 (USD Billion)
    • 8.6.5. Population Screening Market - UAE
      • 8.6.5.1. UAE: Population Screening Market, by Geography, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Population Screening Market, by Application, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Population Screening Market, by Product, 2019-2032 (USD Billion)
    • 8.6.6. Population Screening Market - Israel
      • 8.6.6.1. Israel: Population Screening Market, by Geography, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Population Screening Market, by Application, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Population Screening Market, by Product, 2019-2032 (USD Billion)
    • 8.6.7. Population Screening Market - South Africa
      • 8.6.7.1. South Africa: Population Screening Market, by Geography, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Population Screening Market, by Application, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Population Screening Market, by Product, 2019-2032 (USD Billion)
  • 8.7. Population Screening Market - Latin America
    • 8.7.1. Latin America: Population Screening Market, by Geography, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Population Screening Market, by Application, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Population Screening Market, by Product, 2019-2032 (USD Billion)
    • 8.7.4. Population Screening Market - Mexico
      • 8.7.4.1. Mexico: Population Screening Market, by Geography, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Population Screening Market, by Application, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Population Screening Market, by Product, 2019-2032 (USD Billion)
    • 8.7.5. Population Screening Market - Brazil
      • 8.7.5.1. Brazil: Population Screening Market, by Geography, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Population Screening Market, by Application, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Population Screening Market, by Product, 2019-2032 (USD Billion)
    • 8.7.6. Population Screening Market - Argentina
      • 8.7.6.1. Argentina: Population Screening Market, by Geography, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Population Screening Market, by Application, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Population Screening Market, by Product, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Agilent Technologies
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. QIAGEN
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Roche Ltd
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Quest Diagnostics
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Illumina
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. ARUP Laboratories
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Thermo Fisher Scientific
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Novogene
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. LGC Limited
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Gene by Gene Ltd
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Evoq Technologies
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Eurofins
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development